Antag Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Antag Therapeutics's estimated annual revenue is currently $3.6M per year.
- Antag Therapeutics's estimated revenue per employee is $155,000
- Antag Therapeutics's total funding is $93M.
Employee Data
- Antag Therapeutics has 23 Employees.
- Antag Therapeutics grew their employee count by 15% last year.
Antag Therapeutics's People
Name | Title | Email/Phone |
---|
Antag Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Antag Therapeutics?
Antag Therapeutics is based on years of collaborative research from the University of Copenhagen with the focus on novel treatments for dietary-related metabolic diseases. The research teams of professors Mette M. Rosenkilde and Jens J. Holst have discovered naturally occurring therapeutic peptides that are being investigated in several human studies.
keywords:N/A$93M
Total Funding
23
Number of Employees
$3.6M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 23 | -18% | N/A |
#2 | $2.8M | 23 | 5% | $17.1M |
#3 | $1.6M | 23 | -15% | $6.8M |
#4 | $2.3M | 23 | 10% | N/A |
#5 | $2.3M | 23 | N/A | N/A |